• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Digital Pathology

Accelerating Drug Discovery: Proscia Launches Concentriq Embeddings and AI Toolkit

by Fred Pennic 10/03/2024 Leave a Comment

Accelerating Drug Discovery: Proscia Launches Concentriq Embeddings and AI Toolkit

What You Should Know:  - Proscia, a provider of AI-powered pathology solutions, is accelerating the pace of drug discovery and diagnostic development with the launch of Concentriq® Embeddings and the Proscia AI Toolkit.  - These powerful new tools empower life sciences organizations to leverage the full potential of artificial intelligence in pathology, leading to faster breakthroughs and improved patient outcomes. Transforming AI Development in Pathology Integrated into
Read More

PathPresenter Raises $7.5M to Accelerate Digital Pathology Workflows

by Syed Hamza Sohail 09/12/2024 Leave a Comment

PathPresenter Raises $7.5M to Accelerate Digital Pathology Workflows

What You Should Know: -  PathPresenter, the global image sharing platform for pathology, announced today that it has closed a Series A funding round of $7.5 million to accelerate the adoption of the company’s enterprise pathology workflow solution. - The funding was led by AVANT BIO, with participation from Barco NV and Modi Ventures. The funds will be used to advance the features and interoperability of the vendor-agnostic platform, invest in talent across engineering and commercial
Read More

Fimlab to Deploy Proscia’s AI-Enabled Digital Pathology Platform

by Fred Pennic 09/09/2024 Leave a Comment

Fimlab Partners with Proscia to Advance AI-Enabled Digital Pathology

What You Should Know:  - Fimlab Laboratories, a provider of laboratory services, research, and training, has announced a partnership with Proscia, a global leader in AI-enabled pathology solutions.  - This collaboration will leverage Proscia's software platform to enhance Fimlab's digital pathology capabilities and drive more precise results. The Benefits of Digital Pathology Digital pathology is transforming the way pathologists analyze tissue samples. By transitioning to
Read More

Paige Unveils AI Co-Pilot for Pathology & Oncology, Paige Alba

by Fred Pennic 09/05/2024 Leave a Comment

What You Should Know:  - Paige, a provider of next-generation artificial intelligence has introduced Paige Alba, a groundbreaking clinical-grade multimodal co-pilot designed to transform personalized medicine and precision oncology.  - Leveraging the power of Paige's Foundation Models, Alba delivers real-time AI-driven patient insights, marking a significant step towards Artificial General Intelligence (AGI). A Cohesive Solution for Personalized Medicine Paige Alba
Read More

PathAI’s AISight Dx Receives CE Mark for Primary Diagnosis

by Fred Pennic 08/29/2024 Leave a Comment

PathAI Lands $60M to Accelerate AI-Powered Pathology Platform

What You Should Know:  - PathAI, a pioneer in AI-powered digital pathology, has achieved a significant milestone with the CE mark certification of its AISight Dx Image Management System (IMS) for primary diagnosis.  - The certification paves the way for PathAI's expansion into the European diagnostic pathology market, offering pathologists a powerful tool to enhance their interpretations and improve laboratory efficiency. AISight Dx: A Comprehensive Digital Pathology
Read More

PathAI Introduces AI-Based Measurement for MASH Scoring

by Fred Pennic 08/13/2024 Leave a Comment

PathAI Introduces AI-Based Measurement for MASH Scoring

What You Should Know:  - PathAI, a leader in AI-powered digital pathology solutions, announced today the launch of AIM-MASH on its AISight Image Management System (IMS).  - The new product offers advanced AI-based measurement tools to support pathologists in assessing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) using the MASH Clinical Research Network (CRN) Activity Score. AIM-MASH Integration with AISight By integrating AIM-MASH with AISight, PathAI
Read More

Clarapath Secures $36M to Automate Pathology Labs with AI-Powered Robotics

by Fred Pennic 07/24/2024 Leave a Comment

Clarapath and Mayo Clinic Modernize Pathology Labs with Robotics, AI & Automation

What You Should Know:  - Clarapath, a leading medical robotics company raises $36M in its Series B-1 round led by Northwell Ventures with participation from strategic players like Mayo Clinic and Ochsner Ventures, bringing Clarapath's total funding to $75M. - The company is on a mission to modernize and transform pathology labs through automation and robotics. The Pathology Challenge: Backlog, Labor Shortages, and Manual Processes Pathology, the microscopic examination of
Read More

PathAI Unveils New AI-Powered Pathology Tools for Cancer Research

by Syed Hamza Sohail 05/30/2024 Leave a Comment

PathAI Unveils New AI-Powered Pathology Tools for Cancer Research

What You Should Know: -              PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights. -              The product pairing provides unprecedented single-cell and spatial resolution of
Read More

Providence, Microsoft, UW Develop AI-Powered Pathology Model

by Fred Pennic 05/23/2024 Leave a Comment

Providence, Microsoft, and UW Develop AI-Powered Pathology Model

What You Should Know:  - A collaborative effort between Providence, Microsoft, and the University of Washington has yielded a breakthrough in cancer diagnostics with the development of an AI-powered pathology model, Prov-GigaPath. - Prov-GigaPath is an AI-powered pathology model designed to improve patient care and transform cancer diagnostics. It analyzes entire pathology slides to identify patterns, leading to more accurate mutation predictions and effective cancer subtyping. The
Read More

PathAI Unveils AI Foundation Model Built for Disease Detection

by Jasmine Pennic 05/14/2024 Leave a Comment

PathAI Unveils AI Foundation Model Built for Disease Detection

What You Should Know:  - PathAI, a leader in the field of AI-powered pathology, has announced the launch of Pathology Universal Transformer (PLUTO), a foundation model specifically designed for the intricacies of pathology, promising to transform the development of AI tools for biopharmaceutical companies and pathology labs. - In the realm of machine learning, foundation models (FMs) play a crucial role. These models are trained on vast amounts of unlabeled data using a technique
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 9
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

The AI Paradox in Healthcare: Notable CEO Shares Why Moving Too Slowly is a Greater Risk

Most-Read

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Patient Square Capital Acquires Premier in $2.6B Deal

Pfizer Acquires Metsera for $4.9B, Expanding into Obesity and Cardiometabolic Market

Pfizer Acquires Metsera for $4.9B, Expanding into Obesity and Cardiometabolic Market

CVS Health Subsidiary Omnicare Files for Bankruptcy to Tackle Financial Challenges

CVS Health Subsidiary Omnicare Files for Bankruptcy to Tackle Financial Challenges

Corti Joins Coalition for Health AI to Advance Responsible and Safe AI in Healthcare

Joint Commission and CHAI Release First-Ever Guidance for Responsible AI in Healthcare

71% of Hospitals Now Use Predictive AI, But a Digital Divide Remains

71% of Hospitals Now Use Predictive AI, But a Digital Divide Remains

PHTI Report: Virtual OUD Solutions are Effective, But Don't Substantially Reduce Costs

PHTI Report: Virtual OUD Solutions are Effective, But Don’t Substantially Reduce Costs

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |